How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

May 12, 2026 Hubble has revealed a giant planet-forming disk unlike anything astronomers have seen before. Nicknamed “Dracula’s Chivito,” the enormous structure appears turbulent and oddly lopsided, ...

Call options grant the right to buy stocks at a set price until expiration; puts allow selling. Options expire worthless if stock doesn't reach breakeven, risking the premium paid. Selling options can ...

Daniel Liberto is a journalist with over 10 years of experience working with publications such as the Financial Times, The Independent, and Investors Chronicle. Stella Osoba is the Senior Editor of ...

Katherine Gallagher is a writer and sustainability expert. She holds a B.A. in English Literature from Chapman University and a Sustainable Tourism certificate from the GSTC. The difference between ...